Not logged in.
Quick Search - Contribution
Contribution Details
| Type | Journal Article |
| Scope | Discipline-based scholarship |
| Title | Comment on: F.M. Scherer, "How US antitrust can go astray: the brand name prescription drug litigation" |
| Organization Unit | |
| Authors |
|
| Item Subtype | Original Work |
| Refereed | Yes |
| Status | Published in final form |
| Language |
|
| Journal Title | International Journal of the Economics of Business |
| Publisher | Taylor & Francis |
| Geographical Reach | international |
| ISSN | 1357-1516 |
| Volume | 4 |
| Number | 3 |
| Page Range | 277 - 279 |
| Date | 1997 |
| Abstract Text | Comments on the article `How US Antirust Can Go Astray: The Brand Name Prescription Drug Litigation,' by F.M. Scherer. Discussion of the issue of patent protection; Uniform monopoly price; Summary of price differentiation between groups of consumers. |
| Related URLs | |
| Digital Object Identifier | 10.1080/758523209 |
| PDF File |
Download from ZORA
|
| Export |
BibTeX
EP3 XML (ZORA)
|
| Keywords | Antitrust policy, Price discrimination, Patent protection, Pharmaceutical industry |